Search filters

List of works by Sabine Grimm

Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

scientific article published on 7 February 2017

Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

scientific article published on 01 July 2019

Assessing the Expected Value of Research Studies in Reducing Uncertainty and Improving Implementation Dynamics.

scientific article

Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to “TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases”)

scientific article published in February 2021

Cost assessment of health interventions and diseases

scientific article published on 01 November 2020

Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis

scientific article published on 04 August 2020

Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models

scientific article published on 01 February 2020

EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom ⬇️

scientific article published on 18 October 2017

Health technology assessment: a framework

scientific article published on 01 November 2020

Implementation Barriers to Value of Information Analysis in Health Technology Decision Making: Results From a Process Evaluation

scientific article published in August 2021

Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

scientific article published on 04 November 2020

Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

article

Patient engagement in health technology assessment (HTA) and the regulatory process: what about rheumatology?

scientific article published on 01 November 2020

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

scientific article published on 01 October 2019

State of the ART? Two New Tools for Risk Communication in Health Technology Assessments

scientific article published in October 2021

Steps in implementing a health economic evaluation

scientific article published on 01 November 2020

The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment

scientific article published on 28 August 2017

When Future Change Matters: Modeling Future Price and Diffusion in Health Technology Assessments of Medical Devices.

scientific article published on 21 August 2016

Paulina is supported by:

About Paulina

Help